Skip to content

Drug interactions

Buprenorphine subdermal implant + Hydroxychloroquine

Severity: Moderate

Buprenorphine subdermal implant and Hydroxychloroquine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, though the implant gives low, steady buprenorphine levels. Combined use may modestly increase the risk of arrhythmia in susceptible patients.

What this interaction means in plain words

Buprenorphine subdermal implant and Hydroxychloroquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation via effects on cardiac repolarization.

What to do

Obtain an ECG in patients with cardiac disease or other QT-prolonging drugs and correct electrolyte abnormalities.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Hydroxychloroquine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Hydroxychloroquine?

MediHelp rates the interaction as moderate. Buprenorphine subdermal implant and Hydroxychloroquine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, though the implant gives low, steady buprenorphine levels. Combined use may modestly increase the risk of arrhythmia in susceptible patients.

How serious is the interaction between Buprenorphine subdermal implant and Hydroxychloroquine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG in patients with cardiac disease or other QT-prolonging drugs and correct electrolyte abnormalities.

What other medicines interact with Hydroxychloroquine?

MediHelp also lists interactions of Hydroxychloroquine with, for example, Arsenic trioxide, Cisapride, Dronedarone. The full list is on the Hydroxychloroquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in